Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)—a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy

Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)—a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy #CriticalCare #IntensiveCare https://t.co/hgkDPFFnVE

preliminary data on the use of ilomedine in septic shock. More to come with an on going other RCT: Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS) https://t.co/iZsDYAWC86

Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)-a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy. https://t.co/J7WIDHauAB